Amprius Shares Soar 9.7% to $17.29 After Analysts Lift Targets to $21

AMPXAMPX

Amprius stock climbed to $17.29 intraday and closed 9.7% higher after Cantor Fitzgerald and Craig-Hallum raised target prices to $20 and $21, respectively. The company expects 2025 revenue of $125M (up 71% y/y) and plans accretive growth while cutting net losses to $8M from $44M.

1. Analyst Upgrades and Stock Rally

Amprius shares surged for a fifth consecutive session, hitting an intraday high of $17.29 before closing 9.7% up at $16.33. The rally followed separate upgrades by Cantor Fitzgerald and Craig-Hallum, which raised price targets to $20 and $21 and assigned overweight and buy ratings, respectively.

2. Aggressive Financial Projections

Management forecasts 2025 revenue of $125 million, reflecting a 71% increase from last year and a 417% jump over two years since 2023. Despite strong top-line growth, the company anticipates a net loss of $8 million in 2026, an 82% recovery from the $44 million loss recorded in 2024.

3. Commercial Momentum and Growth Strategy

CEO Tom Stepien highlighted expansion to over 550 customers and tripled revenue in 2025 driven by new program wins and improved manufacturing execution. The firm plans to leverage enhanced supply chain capabilities to scale production of its silicon anode batteries and meet rising market demand.

Sources

F